Anticoagulation Therapy in Patients with Severe COVID-19
Anticoagulation Therapy in Patients with Severe COVID-19
About this item
Full title
Anticoagulation Therapy in Patients with Severe COVID-19
Author / Creator
Publisher
Atlanta: Relias Learning
Journal title
Critical care alert, 2020-06, Vol.28 (3)
Language
English
Formats
Publication information
Publisher
Atlanta: Relias Learning
Subjects
More information
Scope and Contents
Contents
SYNOPSIS: In a retrospective study involving 449 patients with severe COVID-19 requiring intensive care unit admission, those patients with a positive sepsis coagulation score or D-dimer greater than 3.0 mcg/mL who received prophylactic doses of low molecular weight heparin exhibited lower 28-day mortality.
Alternative Titles
Full title
Anticoagulation Therapy in Patients with Severe COVID-19
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_reports_2403851355
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_reports_2403851355
Other Identifiers
ISSN
1067-9502
E-ISSN
1945-1555
How to access this item
Log in as a Library member
